MedInvest Biotech + Pharma Investor Conference
New York, NY 10001
Event summary
This two-day conference featured presentations from more than 40 companies developing and/or commercializing technologies across a broad spectrum of indications – including oncology, immunology, neurology, cardiology, diabetes, infectious, pulmonary, autoimmune, and respiratory diseases, urology, endocrinology, dermatology, pain management and many others. The event also featured talks from key industry opinion leaders, investor panel discussions, and insightful conversations with the National Cancer Institute on patenting, facilitating collaborations, licensing and technology analysis, and marketing.
For more information, please email Kelsey O’Connell.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.